mRNA Expression as a Biomarker of Omalizumab Response

NCT01584687 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Omalizumab

Sponsor

Instituto de Investigação em Imunologia